{"id":168181,"date":"2024-01-04T02:37:51","date_gmt":"2024-01-04T07:37:51","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/hillevax-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference\/"},"modified":"2024-08-18T11:47:23","modified_gmt":"2024-08-18T15:47:23","slug":"hillevax-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/hillevax-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference.php","title":{"rendered":"HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference"},"content":{"rendered":"<p><![CDATA[BOSTON, Jan.  03, 2024  (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 8, 2024 at 4:30 p.m. EST \/ 1:30 p.m. PST. HIL-214, HilleVax\u2019s investigational virus-like particle (VLP) based vaccine for the prevention of moderate-to-severe norovirus-related acute gastroenteritis, and the related ongoing Phase 2b study NEST-IN1 will be topics of discussion.]]><\/p>\n<p>Visit link:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/01\/03\/2803672\/0\/en\/HilleVax-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference\">HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Visit link: HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/hillevax-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-168181","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168181"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=168181"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168181\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=168181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=168181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=168181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}